7+Years of programmes
MultiMedical disciplines
GlobalSpeaker network
TrustedBy academia & industry
From fundamental research to industrial translation — GCNN 2027 invites original contributions across the full breadth of neurology.
Acute stroke care has been redefined by tenecteplase displacing alteplase as the preferred thrombolytic, late-window thrombectomy out to 24 hours guided by perfusion imaging (DAWN, DEFUSE-3), and increasingly the treatment of medium and distal vessel occlusions.
ExploreThe approval of lecanemab and donanemab has transformed Alzheimer’s disease into a treatable condition for patients with early symptomatic disease and confirmed amyloid pathology.
ExploreThe MS pipeline is converging on the central goal of halting smoldering, compartmentalized CNS inflammation that drives progression independent of relapse activity (PIRA).
ExploreMovement disorders are entering a precision-medicine era, with genetically stratified trials in GBA1 (LTI-291/venglustat lessons, BIA 28-6156) and LRRK2 (BIIB122/DNL151) carriers redefining trial design.
ExploreDrug-resistant epilepsy continues to affect roughly a third of patients despite an expanding pharmacopeia, prompting earlier escalation to surgical and neuromodulation approaches.
ExploreNeuromuscular medicine has been reshaped by genetically targeted therapies: nusinersen, onasemnogene abeparvovec and risdiplam in SMA, exon-skipping ASOs and Elevidys gene therapy in Duchenne, and tofersen for SOD1-ALS following the VALOR trial and accelerated approval.
ExploreGCNN 2027 is a global forum for pioneering research, clinical translation and cross-disciplinary dialogue across the full spectrum of neurology and neuroscience.
Across two days of keynotes, parallel technical tracks, poster sessions and focused workshops, we convene the brightest minds to chart the frontier of brain science — from molecular mechanisms to clinical impact.
GCNN 2027 is more than a conference — it is a launchpad for your research, your clinical practice, and your next translational collaboration.
Hear first on breakthrough findings across 35 scientific sessions in neurology.
Keynote, plenary and invited speakers from leading US and international institutions.
Connect with researchers, clinicians and industry leaders across 12+ countries — in one room, over two days.
All accepted abstracts published in the ISBN-allocated proceedings; selected papers invited to partner journals.
Best Paper, Best Poster and Young Investigator awards with global visibility and certificates of excellence.
Two days of curated networking and a gala dinner — attend on-site in the USA or stream every session live, worldwide.
Early-bird pricing available until July 14, 2026. All fees include the full two-day program, conference kit, lunches and networking events.
Mark these deadlines to stay ahead of abstract submission, registration and arrival.
Everything you need to submit abstracts, prepare presentations, and share GCNN 2027 with your colleagues.